BioCentury
ARTICLE | Clinical News

Arglabin farnesyl transferase inhibitor regulatory update

May 1, 2000 7:00 AM UTC

NLAB subsidiary International Phytochemistry Research Labs Ltd. received U.S. Patent No. 6,051,565 covering a family of phosphosesquiterpene compounds and their use to treat various cancers. The compo...